iQure Pharma Targets Future with New Board Appointments
Life Sciences industry experts Michael D. Webb and Brian Cain bring extensive expertise in strategic pharmaceutical growth DELAWARE,...
News
Search
- Jun 22, 2020
iQure Pharma Inc. Announces Dr. Katrin Rupalla as the newest member of their Board of Directors
Delaware – June 2020, iQure Pharma Inc., a company dedicated to preclinical and early clinical development of Oncology and Central...
- Apr 16, 2020
iQure Pharma Inc. announces the Appointment of Professor Thomas Rades as CMC Advisor
Delaware – April 2020, iQure Pharma Inc., a company dedicated to preclinical and early clinical development of Oncology and Central...
- Nov 18, 2019
iQure Pharma Inc. announces the Appointment of Dr. Joseph Wettstein, as Chief Scientific Officer
Delaware – November 2019, iQure Pharma Inc., a company dedicated to preclinical and early development of oncology and CNS compounds,...